- Home
- WKHS vs CUE Comparison
WKHS vs CUE Comparison
Compare WKHS & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKHS | CUE |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 17.6M |
| IPO Year | 2008 | 2017 |
Fundamental Metrics
Financial Performance| Metric | WKHS | CUE |
|---|---|---|
| Price | $2.58 | $0.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $21.00 | $3.00 |
| AVG Volume (30 Days) | 76.8K | ★ 1.0M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.92 | 61.11 |
| EPS | N/A | ★ N/A |
| Revenue | $763,173.00 | ★ $27,466,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $105.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 195.75 |
| 52 Week Low | $0.53 | $0.17 |
| 52 Week High | $11.80 | $1.03 |
Technical Indicators
Market Signals| Indicator | WKHS | CUE |
|---|---|---|
| Relative Strength Index (RSI) | 30.20 | 25.60 |
| Support Level | $0.92 | N/A |
| Resistance Level | $3.60 | $0.35 |
| Average True Range (ATR) | 0.22 | 0.02 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 10.34 | 4.09 |
Price Performance
Historical ComparisonAbout WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.